Tag: Eli Lilly

Isomorphic inks deals with Eli Lilly and Novartis for drug discovery

Isomorphic Labs, a drug discovery-focused spin-out of Google AI R&D division DeepMind, has partnered with pharmaceutical giants Eli Lilly and Novartis to leverage AI in discovering new medications to treat diseases, with combined deals valued at around $3 billion.   Isomorphic draws on DeepMind’s AlphaFold 2 AI technology to predict the structure of proteins in […]

©2023 The Horizon